Corporate News
In the following you will find the corporate news made public by Vita 34:
Thomas Pfaadt appointed as new Chief Financial Officer of Vita 34 AG
EQS-News: Vita 34 AG / Key word(s): PersonnelThomas Pfaadt appointed as new Chief Financial Officer of
Vita 34 significantly increases earnings and operating cash flow in the first quarter
EQS-News: Vita 34 AG / Key word(s): Quarterly / Interim StatementVita 34 significantly increases earnings
Vita 34 returns to growth path in 2023
EQS-News: Vita 34 AG / Key word(s): Annual ResultsVita 34 returns to growth path in 2023 30.04.2024 /
Vita 34 downsizes Management Board until further notice
EQS-News: Vita 34 AG / Key word(s): PersonnelVita 34 downsizes Management Board until further notice
Vita 34 increases revenue and earnings in Q3 2023 and further stabilizes business development
EQS-News: Vita 34 AG / Key word(s): Quarter ResultsVita 34 increases revenue and earnings in Q3 2023
Vita 34 stabilizes business development in the second quarter and noticeably improves earnings
EQS-News: Vita 34 AG / Key word(s): Half Year ResultsVita 34 stabilizes business development in the second
Vita 34 successfully implements price increases in first quarter of 2023 in generally weak market environment
EQS-News: Vita 34 AG / Key word(s): Quarter ResultsVita 34 successfully implements price increases in
Vita 34 Starts Recruitment for Clinical Trial with CAR-T Drug Candidate
EQS-News: Vita 34 AG / Key word(s): StudyVita 34 Starts Recruitment for Clinical Trial with CAR-T Drug
Development of Vita 34 AG in 2022 stressed by weakened consumption power of consumers along with one-off effects
EQS-News: Vita 34 AG / Key word(s): Annual ResultsDevelopment of Vita 34 AG in 2022 stressed by weakened
Vita 34 benefits from increasing normalization in its core business in the third quarter
EQS-News: Vita 34 AG / Key word(s): 9 Month figuresVita 34 benefits from increasing normalization in
Vita 34 records moderate upward trend in the second quarter
DGAP-News: Vita 34 AG / Key word(s): Half Year Results/Half Year ReportVita 34 records moderate upward
Vita 34 introduces new Chief Financial Officer at the Annual General Meeting
DGAP-News: Vita 34 AG / Key word(s): AGM/EGMVita 34 introduces new Chief Financial Officer at the Annual
Vita 34 sees first signs of stabilization in core business after war-related weaker first quarter
DGAP-News: Vita 34 AG / Key word(s): Quarter ResultsVita 34 sees first signs of stabilization in core
Vita 34 AG: Special items reflected in significant decline in earnings despite operational success in fiscal 2021
DGAP-News: Vita 34 AG / Key word(s): Annual ResultsVita 34 AG: Special items reflected in significant
Vita 34 sets course for accelerated growth in new business areas with changes in the Management Board
DGAP-News: Vita 34 AG / Key word(s): Personnel/Strategic Company Decision18.03.2022 / 20:21 The issuer
Vita 34 presents itself in new size for the first time at the Annual General Meeting 2021
DGAP-News: Vita 34 AG / Key word(s): AGM/EGM15.12.2021 / 18:14 The issuer is solely responsible for the
Vita 34 again increases sales and margins in the third quarter
DGAP-News: Vita 34 AG / Key word(s): Quarter Results11.11.2021 / 07:30 The issuer is solely responsible
Vita 34 AG extends the acceptance period under PBKM exchange offer
DGAP-News: Vita 34 AG / Key word(s): Miscellaneous11.10.2021 / 08:00 The issuer is solely responsible
Vita 34 AG launches voluntary public exchange offer for PBKM shares
DGAP-News: Vita 34 AG / Key word(s): Miscellaneous20.09.2021 / 08:00 The issuer is solely responsible
Vita 34 again achieves double-digit growth in revenues and earnings in the first half of the year
DGAP-News: Vita 34 AG / Key word(s): Half Year Results31.08.2021 / 07:30 The issuer is solely responsible
Vita 34 AG: Andreas Schafhirt appointed as new Chief Financial Officer of Vita 34 AG
DGAP-News: Vita 34 AG / Key word(s): Personnel16.08.2021 / 09:30 The issuer is solely responsible for
Vita 34 publishes figures for the first quarter of 2021
DGAP-News: Vita 34 AG / Key word(s): Quarter Results31.05.2021 / 11:00 The issuer is solely responsible
Vita 34 AG signs Business Combination Agreement with Polski Bank Komórek Macierzystych S.A.
DGAP-News: Vita 34 AG / Key word(s): Mergers & Acquisitions/Capital Increase31.05.2021 / 10:07 The issuer
Vita 34 continues to grow in 2020 in core markets after good year-end business
DGAP-News: Vita 34 AG / Key word(s): Annual Results30.03.2021 / 07:30 The issuer is solely responsible
Vita 34 manages crisis environment well with a strong third quarter
DGAP-News: Vita 34 AG / Key word(s): 9 Month figures12.11.2020 / 07:30 The issuer is solely responsible
Business development of Vita 34 gains significant momentum again in the second quarter
DGAP-News: Vita 34 AG / Key word(s): Half Year Results27.08.2020 / 07:30 The issuer is solely responsible
Business development of Vita 34 stable and unaffected by COVID-19 development so far
DGAP-News: Vita 34 AG / Key word(s): Quarter Results14.05.2020 / 07:30 The issuer is solely responsible
Vita 34 successfully concludes also fourth quarter 2019 with organic growth
DGAP-News: Vita 34 AG / Key word(s): Annual Results23.03.2020 / 07:30 The issuer is solely responsible
Vita 34 concludes 2019 with significant earnings growth
DGAP-News: Vita 34 AG / Key word(s): Preliminary Results13.03.2020 / 08:00 The issuer is solely responsible
Sales growth in core markets further increases margins for Vita 34
DGAP-News: Vita 34 AG / Key word(s): Quarterly / Interim Statement21.11.2019 / 07:30 The issuer is solely
Vita 34 closes first half-year 2019 with operating profit margins at record levels
DGAP-News: Vita 34 AG / Key word(s): Half Year Results29.08.2019 / 07:30 The issuer is solely responsible
Annual General Meeting of Vita 34 AG agrees in all agenda items with the administration
DGAP-News: Vita 34 AG / Key word(s): AGM/EGM/Dividend05.06.2019 / 10:56 The issuer is solely responsible
Vita 34 significantly increases profitability in the first quarter and paves the way for expansion of the product portfolio
DGAP-News: Vita 34 AG / Key word(s): Quarter Results09.05.2019 / 07:30 The issuer is solely responsible
Vita 34 surpasses full-year guidance for 2018 at earnings level
DGAP-News: Vita 34 AG / Key word(s): Annual Results28.03.2019 / 07:15 The issuer is solely responsible
Vita 34 concludes 2018 with significant earnings growth according to preliminary figures
DGAP-News: Vita 34 AG / Key word(s): Preliminary Results28.02.2019 / 08:00 The issuer is solely responsible
Vita 34 develops cell preparations as the source material for immune cell therapies and becomes cell bank
DGAP-News: Vita 34 AG / Key word(s): Strategic Company Decision08.02.2019 / 08:00 The issuer is solely
Vita 34 records increasing number of uses of umbilical cord blood
DGAP-News: Vita 34 AG / Key word(s): Miscellaneous12.12.2018 / 13:56 The issuer is solely responsible
Vita 34 quadruples earnings with a clear increase in margins
DGAP-News: Vita 34 AG / Key word(s): Quarter Results22.11.2018 / 07:30 The issuer is solely responsible
Vita 34 AG: Half-year figures characterized by increasing momentum in core market Germany
DGAP-News: Vita 34 AG / Key word(s): Half Year Results30.08.2018 / 07:30 The issuer is solely responsible
Vita 34 refocuses R&D activities and implements cost reduction program in Scandinavia
DGAP-News: Vita 34 AG / Key word(s): Miscellaneous26.06.2018 / 14:00 The issuer is solely responsible
Vita 34 introduces entry-level pricing model ‘VitaPur’ and implements first cost reduction measures
DGAP-News: Vita 34 AG / Key word(s): Product Launch/Regulatory Approval17.05.2018 / 07:28 The issuer
Vita 34 achieves further growth in market share and margin in the first quarter
DGAP-News: Vita 34 AG / Key word(s): Quarter Results09.05.2018 / 07:10 The issuer is solely responsible
Vita 34 AG: Continued Growth Trend Following Acquisition – Vita 34 with Further Significant Sales and Earnings Growth in Q4
DGAP-News: Vita 34 AG / Key word(s): Final Results28.03.2018 / 07:10 The issuer is solely responsible
Vita 34 AG: Strong New Customer Business Allows Vita 34 to Grow Significantly in Q3
DGAP-News: Vita 34 AG / Key word(s): 9-month figures/Quarter Results23.11.2017 / 07:30 The issuer is
Vita 34 and Berlin Charité launch joint research project
DGAP-News: Vita 34 AG / Key word(s): Study/Alliance25.10.2017 / 10:32 The issuer is solely responsible
Vita 34 completes Management Board with the return of Falk Neukirch
DGAP-News: Vita 34 AG / Key word(s): Change of Personnel08.09.2017 / 13:15 The issuer is solely responsible
Vita 34 AG: Vita 34 Lays Foundation for Future Growth During H1 2017
DGAP-News: Vita 34 AG / Key word(s): Half Year Results/Interim Report30.08.2017 / 07:15 The issuer is
Vita 34 adjusts targets for 2017 and increases capital market communication
DGAP-News: Vita 34 AG / Key word(s): Change in Forecast/Change of Personnel08.08.2017 / 11:05 The issuer
Vita 34 completes rights issue – multiple times oversubscribed
DGAP-News: Vita 34 AG / Key word(s): Capital Increase28.07.2017 / 19:45 The issuer is solely responsible
Vita 34 AG reports on Annual General Meeting and dividend distribution
DGAP-News: Vita 34 AG / Key word(s): AGM/EGM28.06.2017 / 23:35 The issuer is solely responsible for the
Vita 34 AG signs cooperation agreement with Romanian company Besmax Life Solutions SRL
DGAP-News: Vita 34 AG / Key word(s): Alliance27.06.2017 / 07:30 The issuer is solely responsible for
Vita 34 AG acquires MK Beleggingsmaatschappij Venlo B.V. as a new strategic investor and secures support for further corporate action
DGAP-News: Vita 34 AG / Key word(s): Investment14.06.2017 / 19:28 The issuer is solely responsible for
Vita 34 AG has a Successful Start in Current Fiscal Year 2017
DGAP-News: Vita 34 AG / Key word(s): Quarter Results16.05.2017 / 07:30 The issuer is solely responsible
Vita 34 AG: Chief Financial Officer of Vita 34 AG to seek new challenges
DGAP-News: Vita 34 AG / Key word(s): Change of Personnel01.05.2017 / 07:00 The issuer is solely responsible
Vita 34 AG Achieves Strongest Growth Since 2010
DGAP-News: Vita 34 AG / Key word(s): Final Results/Preliminary Results13.03.2017 / 07:00 The issuer is
Vita 34 AG increased its turnover in 2016 by 14 per cent in comparison to the previous year
DGAP-News: Vita 34 AG / Key word(s): Final Results/Preliminary Results01.02.2017 / 07:00 The issuer is
Vita 34 AG: Strong Sales Trend in the First Nine Months of 2016
DGAP-News: Vita 34 AG / Key word(s): 9-month figures2016-11-21 / 07:30 The issuer is solely responsible
Vita 34 Receives Patent for the Preparation of Umbilical Cord Tissue for Cryo-Preservation
DGAP-News: Vita 34 AG / Key word(s): Patent2016-10-12 / 07:30 The issuer is solely responsible for the
Vita 34 AG: Dividend Increased by 7 Percent
DGAP-News: Vita 34 AG / Key word(s): AGM/EGM/Dividend2016-08-25 / 13:45 The issuer is solely responsible
Vita 34 Increases Revenue by 25 Percent in First Half-Year 2016
DGAP-News: Vita 34 AG / Key word(s): Half Year Results2016-08-23 / 07:00 The issuer is solely responsible
Vita 34 AG: Vita 34 starts successful into 2016; Total Operating Revenue up by 16.3 percent
DGAP-News: Vita 34 AG / Key word(s): Quarterly / Interim Statement2016-05-25 / 10:10 The issuer is solely
Vita 34 AG: Management Board at Vita34 AG expanded with Director of Sales and Marketing
DGAP-News: Vita 34 AG / Key word(s): Change of Personnel2016-05-17 / 18:08 The issuer is solely responsible
Vita 34 AG improves total operating revenue, profitability, and dividend
DGAP-News: Vita 34 AG / Key word(s): Final Results2016-03-30 / 07:04 The issuer is solely responsible
Vita 34 AG increases Earnings per Share by 39.8 Percent to EUR 0.23
DGAP-News: Vita 34 AG / Key word(s): Quarter Results2015-11-12 / 06:58 Vita 34 AG increases Earnings
Vita 34 AG: New Chief Financial Officer for Vita 34 AG
DGAP-News: Vita 34 AG / Key word(s): Change of Personnel2015-09-28 / 07:04 Vita 34 AG: New Chief Financial
Vita 34 AG: First Dividend Payment
Vita 34 AG / Key word(s): AGM/EGM2015-07-28 / 14:41 Vita 34 AG: First Dividend PaymentLeipzig, July 28,
Vita 34 Strengthens Market Position via Investments
Vita 34 AG / Key word(s): Investment2015-07-02 / 07:28 Vita 34 Strengthens Market Position via InvestmentsLeipzig,
Vita 34 Further Expands R&D Activities and Gains Important Insights in Stem Cell Research
Vita 34 AG / Key word(s): Miscellaneous2015-06-08 / 07:33 Vita 34 Further Expands R&D Activities
Vita 34 AG: Q1 2015 Confirms Expectations for the Current Year
Vita 34 AG / Key word(s): Quarter Results2015-04-23 / 07:31 Vita 34 AG: Q1 2015 Confirms Expectations
Vita 34 Confirms Earnings Increase of 28.6 Percent per Share 2014
Vita 34 AG / Key word(s): Final Results2015-03-26 / 07:33 Vita 34 Confirms Earnings Increase of 28.6
Vita 34 AG Publishes Preliminary Figures for Fiscal Year 2014
Vita 34 AG / Key word(s): Preliminary Results2015-03-05 / 07:31 Vita 34 AG Publishes Preliminary Figures
Vita 34 Expands International Market Presence – Apart from Germany Now Active in 20 Other Countries
Vita 34 AG / Key word(s): Alliance08.01.2015 / 07:52Vita 34 Expands International Market Presence – Apart
Vita 34 AG: Positive Development of Business in the First Nine Months of 2014
Vita 34 AG / Key word(s): 9-month figures23.10.2014 / 07:58Vita 34 AG: Positive Development of Business
Vita 34 AG: Successful Annual General Meeting 2014
Vita 34 AG / Key word(s): AGM/EGM28.08.2014 / 18:57Vita 34 AG: Successful Annual General Meeting 2014Leipzig,
Vita 34 AG Publishes Financial Figures for the First Half-Year 2014
Vita 34 AG / Key word(s): Half Year Results24.07.2014 / 07:35Vita 34 AG Publishes Financial Figures for
Vita 34 AG Expands its R&D Activities to Include Research Projects Involving Autologous Fatty Tissue and a New Project Phase in the Production of Active Agents
Vita 34 AG / Key word(s): Miscellaneous18.06.2014 / 14:03Vita 34 AG Expands its R&D Activities to
Vita 34 AG: Close Brothers Seydler Starts Coverage of Vita 34 Stock
Vita 34 AG / Key word(s): Miscellaneous13.05.2014 / 10:48Vita 34 AG: Close Brothers Seydler Starts Coverage
Vita 34 AG: Increase in Profitability in Q1 Confirms Positive Growth Outlook 2014
Vita 34 AG / Key word(s): Quarter Results24.04.2014 / 07:35Vita 34 AG: Increase in Profitability in Q1
Vita 34 AG: Vita 34 AG Starts Fiscal Year 2014 Highly-Profitable and Full of Optimism
Vita 34 AG / Key word(s): Final Results27.03.2014 / 07:48Vita 34 AG Starts Fiscal Year 2014 Highly-Profitable
Vita 34 AG pursues growth strategy by taking over the majority stake in Stellacure
Vita 34 AG / Key word(s): Investment07.01.2014 / 17:14Vita 34 AG pursues growth strategy by taking over
Vita 34 AG: Positive Development of Business in the First Nine Months and Increase in 2013 Annual Forecast
Vita 34 AG / Key word(s): Quarter Results/Change in Forecast24.10.2013 / 07:42Vita 34 AG: Positive Development
Vita 34 AG: Expansion of Product Range with Permit for Collecting Umbilical Cord Tissue
Vita 34 AG / Key word(s): Miscellaneous26.09.2013 / 08:01Vita 34 AG: Expansion of Product Range with
Vita 34 AG: Successful Annual General Meeting with Notable Approval of Shareholders
Vita 34 AG / Key word(s): AGM/EGM25.07.2013 / 12:16Vita 34 AG: Successful Annual General Meeting with
Vita 34 AG: Vita 34 returns to Profitability
Vita 34 AG / Key word(s): Half Year Results25.07.2013 / 07:34Vita 34 AG: Vita 34 returns to Profitability-
Vita 34 AG: Expansion of Foreign Business with Partners in Eastern Europe
Vita 34 AG / Key word(s): Alliance08.07.2013 / 09:53Vita 34 AG: Expansion of Foreign Business with Partners
VITA 34 AG: VITA 34 extends foreign business in Southeast Europe through cooperation
VITA 34 AG / Key word(s): Alliance12.06.2012 / 07:45 VITA 34 AG: VITA 34 extends foreign business in
VITA 34 International AG: VITA 34 International AG expands to Slovakia
VITA 34 International AG / Key word(s): Miscellaneous22.06.2011 / 10:38 VITA 34 International AG expands
VITA 34 International AG: Exclusive agreement with Italian partner renewed prematurely
VITA 34 International AG / Key word(s): AllianceVITA 34 International AG: Exclusive agreement with Italian
VITA 34 International AG: VITA 34 and Hannover Medical School start project on iPS cells
VITA 34 and Hannover Medical School start project on iPS cells Leipzig, June 7, 2010 – The VITA 34 International
VITA 34 partners with CompuGROUP to inform doctors on umbilical cord blood
Leipzig, March 8, 2010. VITA 34 International AG (ISIN DE000A0BL849), the parent company of the largest
VITA 34 International AG: General Meeting approves all items on the agenda with more than 99 percent
Leipzig, 15 July 2009 – The shareholders of VITA 34 International AG (ISIN DE000A0BL849), the holding
VITA 34 International AG: VITA 34 expanding into Slovenia
Leipzig, February 11, 2009 – VITA 34 International AG (ISIN DE000A0BL849), the parent company of the
VITA 34 International AG increases revenues in Q1 200, setting the course for further growth
Revenues of EUR 3.6 million. • EBIT of EUR -0.3 million as planned • Period result in the group of
VITA 34 Signs Cooperation Agreement with BKK Gruner + Jahr
Leipzig, February 06, 2008 – VITA 34 International AG (ISIN DE000A0BL849), parent company of VITA 34,
Vita 34 International AG: Spanish partner Secuvita takes a share in VITA 34
New major shareholder with strategic interest – strong growth in Spain Leipzig/Madrid, September 27,
Vita 34 International AG: Further collaboration agreed with a compulsory health insurance fund, BKK Ost-Hessen supports the storage of umbilical cord blood at VITA 34
Leipzig, 1 September 2007 – VITA 34 International AG (ISIN DE000A0BL849), the parent company of the leading
VITA 34 International AG presents report for the 1st quarter of 2007 – Strong growth in all areas
Leipzig, April 27, 2007 – VITA 34 International AG (ISIN DE000A0BL849), parent company of VITA 34, the
Vita 34 International AG: Publication in accordance with § 26 section 1 WpHG of the information about shares in accordance with § 21 Abs. 1a WpHG
The Sachsen LB, Leipzig, Germany, has informed us in accordance with § 21 section 1a WpHG, that her share